Insider Trading24 Sept 2026, 09:59 pm
Shukra Pharmaceuticals Closes Trading Window
AI Summary
Shukra Pharmaceuticals Ltd has announced the closure of its trading window for dealing in the company's securities. This restriction applies to promoters, directors, key management personnel, insiders, and designated/connected persons, along with their immediate relatives. The window will remain closed from October 1, 2026, until 48 hours after the declaration of the Unaudited Financial Results for the quarter ended September 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and related circulars and the company's internal code. The date of the board meeting to approve these results will be announced separately.
Key Highlights
- Trading window closed for designated persons and insiders.
- Closure is effective from October 1, 2026.
- Restriction lasts until 48 hours post Q2 FY27 results declaration.
- Aims to prevent insider trading as per SEBI regulations.
- Board meeting date for results approval to be announced.
Price Impact
More from SHUKRAPHAR